• Register
  • Login

European Journal of Molecular & Clinical Medicine

  1. Home
  2. 50 SHADES OF GREY: DOES SERUM PROCALCITONIN PREDICT ALL CAUSE MORTALITY IN PATIENTS WITH SEPSIS AND SEPTIC SHOCK?

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

Journal Metrics

News

50 SHADES OF GREY: DOES SERUM PROCALCITONIN PREDICT ALL CAUSE MORTALITY IN PATIENTS WITH SEPSIS AND SEPTIC SHOCK?

    Author

    • Dr. Anurag Singh Chauhan, Dr. Manisha Thakur, Dr. Kavita Yadav, Dr.Kishori Lal Meena, Dr. Ghanshyam Gahlot
,

Document Type : Research Article

  • Article Information
  • Download
  • Export Citation
  • Statistics
  • Share

Abstract

Background: The concept, definition and understanding of sepsis may have undergone several changes in the past years, but its omniscient nature in modern day critical care medicine has made accurate diagnosis, early initiation of therapy and relatively accurate prognostication, imperative. In recent times, procalcitonin has been used to initiate, de-escalate and guide antibiotic therapy. However, the data on its ability to predict all cause mortality in patients with sepsis remains nebulous. There is adequate evidence to merit considering both sides of the story.
Methods: We studied 99 consecutive patients meeting the diagnostic criteria for sepsis according to Sepsis 3 consensus criteria. Serum procalcitonin levels were compared head to head with 30-day all-cause mortality. Chi squarepaired and unpaired T and Pearson’s coefficient were used to analyze the data. 
Results: Our study showed that patients with a higher baseline value of serum procalcitonin had higher rate of in-hospital mortality (SD – 1.8 vs SD - 0.68, 2-tailed P<0.001). However, no statistically significant association was noted between baseline PCT and duration of ICU stay.
Conclusions: The predictive value of serum PCT, for mortality has been a matter of debate and controversy with compelling evidence to both sides of the story available in contemporary literature. Our study re-enforces the dictum of early diagnosis and treatment of sepsis in conjunction with the judicious use of serum procalcitonin. On the horizon, the authors see a plethora of newer biomarkers (SUPAR and sTREM-1) which may be used standalone or in combination to improve outcomes.

Keywords

  • sepsis
  • septic shock
  • Procalcitonin
  • XML
  • PDF 257.84 K
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
    • Article View: 81
    • PDF Download: 100
European Journal of Molecular & Clinical Medicine
Volume 9, Issue 3
February 2022
Page 11456-11462
Files
  • XML
  • PDF 257.84 K
Share
Export Citation
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
Statistics
  • Article View: 81
  • PDF Download: 100

APA

Gahlot, D. A. S. C. D. M. T. D. K. Y. D. L. M. D. G. (2022). 50 SHADES OF GREY: DOES SERUM PROCALCITONIN PREDICT ALL CAUSE MORTALITY IN PATIENTS WITH SEPSIS AND SEPTIC SHOCK?. European Journal of Molecular & Clinical Medicine, 9(3), 11456-11462.

MLA

Dr. Anurag Singh Chauhan, Dr. Manisha Thakur, Dr. Kavita Yadav, Dr.Kishori Lal Meena, Dr. Ghanshyam Gahlot. "50 SHADES OF GREY: DOES SERUM PROCALCITONIN PREDICT ALL CAUSE MORTALITY IN PATIENTS WITH SEPSIS AND SEPTIC SHOCK?". European Journal of Molecular & Clinical Medicine, 9, 3, 2022, 11456-11462.

HARVARD

Gahlot, D. A. S. C. D. M. T. D. K. Y. D. L. M. D. G. (2022). '50 SHADES OF GREY: DOES SERUM PROCALCITONIN PREDICT ALL CAUSE MORTALITY IN PATIENTS WITH SEPSIS AND SEPTIC SHOCK?', European Journal of Molecular & Clinical Medicine, 9(3), pp. 11456-11462.

VANCOUVER

Gahlot, D. A. S. C. D. M. T. D. K. Y. D. L. M. D. G. 50 SHADES OF GREY: DOES SERUM PROCALCITONIN PREDICT ALL CAUSE MORTALITY IN PATIENTS WITH SEPSIS AND SEPTIC SHOCK?. European Journal of Molecular & Clinical Medicine, 2022; 9(3): 11456-11462.

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Glossary
  • Sitemap

News

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

© Journal Management System. Powered by ejournalplus